We were proud to participate in ISPOR Europe 2025 in Glasgow, Scotland one of the world’s leading congresses for Health Economics and Outcomes Research (HEOR).This year, Health Through Evidence presented six research posters, reflecting our expanding footprint...
📍 Last week, Health Through Evidence had the pleasure of participating in and supporting the 10th HTA Conference 2025, themed “HTA in Transition: Delivering Value Through Inclusive Health Policies”, organized by Health Daily and BOUSSIAS, held on September 30th in...
Health Through Evidence (HTE) for World Inflammatory Bowel Disease Day 2025 by Marina Psarra, MSc, Biologist-Medical writer. Inflammatory Bowel Disease (IBD), encompassing Crohn’s disease and ulcerative colitis, continues to impose a significant burden on individuals...
We are pleased to announce the results of our latest #study, conducted in collaboration with HELLESCC | Hellenic Society of Crohn Disease And Ulcerative Colitis Patients. Our findings highlight a critical insight: a significant proportion of patients with...
Delighted to have been part of European Crohn’s and Colitis Organization in Berlin, Germany! We are happy to share that our research study, titled "Patient-reported outcomes in a Greek cross-sectional survey of inflammatory bowel disease patients treated with biologic...